Evaluation of biodegradable rifampicin-bearing microsphere formulations using a stability-indicating high-performance liquid chromatographic assay

European Journal of Pharmaceutical Sciences

Volumn 7, Issue 1, 1998, Pages 57-65

  Bain, David F ^a   Munday, Dale L ^a   Cox, Philip J ^a  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

Biodegradable; Dissolution; High performance liquid chromatography; Microsphere; Rifampicin; Stability

Indexed keywords

MICROSPHERE; RIFAMPICIN;

ARTICLE; BIODEGRADATION; CONTROLLED STUDY; DISSOLUTION; DRUG DETERMINATION; DRUG FORMULATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PH; PRIORITY JOURNAL;

ANTIBIOTICS, ANTITUBERCULAR; ANTIOXIDANTS; ASCORBIC ACID; BIOCOMPATIBLE MATERIALS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; KINETICS; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; REPRODUCIBILITY OF RESULTS; RIFAMPIN;

EID: 0032413314     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(98)00005-0     Document Type: Article

References (19)

1. Bain D.F., Munday D.L., Cox P.J. Preparation of rifampicin-bearing biodegradable microspheres. Eur. J. Pharm. Sci. 4:1996;S131.
2. Bayer R., Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet. 345:1995;1545-1548.
3. Bell C., Ip D.P. Utility of column switching to analyse low dose dissolution samples for pharmaceutical formulations. J. Pharm. Biomed. Anal. 11:1993;171-181.
4. Braggio S., Barnaby R.J., Grossi P.et al. A strategy for validation of bioanalytical methods. J. Pharm. Biomed. Anal. 14:1996;375.
5. British National Formulary, 1995, 30th edition, The General Medical Association and The Royal Pharmaceutical Society of Great Britain.
6. Gallo, G.G., Radaelli, P., Rifampin. In: Florey, K. (Ed.), Analytical profiles of drug substances. Academic Press, New York, 1968, pp. 467-513.
7. Gharbo S.A., Cognion M.M., Williamson M.J. Modified dissolution method for rifampicin. Drug Dev. Ind. Pharm. 15:1989;331-335.
8. Graham K.C. High-performance liquid chromatographic analysis of rifampicin and related impurities in pharmaceutical impurities. J. Liq. Chromatogr. 2:1979;365-371.
9. Karlson A.G., Ulrich J.A. Stability of rifampicin in dimethylsulfoxide. Appl. Microbiol. 18:1969;692-693.
10. Krukenberg C.C., Mischler P.G., Massad E.N.et al. Stability of 1% rifampin suspensions prepared in five syrups. Am. J. Hosp. Pharm. 43:1996;2225-2228.
11. Jindal K.C., Chaudary R.S., Singla A.K.et al. Effects of buffers and pH on rifampicin stability. Pharm. Ind. 57:1995;420-422.
12. Maggi N., Vigevani A., Gallo G.G.et al. Acetyl migration in rifampicin. Experementia. 11:1968;936-939.
13. Maulding H.V., Tice T.R., Cowsar D.R.et al. Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. J. Control. Rel. 3:1986;103-117.
14. Nahata M.C., Morosco R.S., Hipple T.F. Effect of preparation method and storage on rifampicin concentration in suspensions. J. Clin. Pharm. Ther. 28:1994;182-184.
15. Prankerd R.J., Stella V.J. Equilibria and kinetics of hydrolysis of ebifuramin (NSC-201047), an azommethine-containing structure exhibiting a reversible degradation step in acidic solutions. Int. J. Pharm. 52:1989;71-78.
16. Prankerd R.J., Walters J.M., Parnes J.H. Kinetics for degradation of rifampicin, an azomethine-containing drug which exhibits reversible hydrolysis in acidic solution. Int. J. Pharm. 78:1992;56-67.
17. Seydel J.K. Physicochemical studies of rifampicin. Antibiot. Chemotherapia. 16:1970;380-391.
18. Taylor R.B., Richards R.M.E., Low A.S., Hardie L. Chemical stability of polymyxin in aqueous solution. Int. J. Pharm. 102:1994;201-206.
19. Wade, A. (Ed.), 1980. In: Pharmaceutical Handbook, 19th Edition, The Pharmaceutical Press, p. 239.